Mayavan
Viji
and
Rajagopal
Nagarajan
*
School of Chemistry, University of Hyderabad, Hyderabad 500 046, India. E-mail: rnsc@uohyd.ernet.in; Fax: +91 40 66794831
First published on 6th September 2012
We explored the zinc triflate catalyzed heteroannulation reaction of 3-aminocarbazoles with substituted propargyl alcohols to form pyrrolo[2,3-c]carbazoles in moderate to good yields. This transformation proceeds with good regioselectivity and without the addition of additives or ligands.
![]() | ||
| Fig. 1 Structure of some of the Dictyodendrin alkaloids. | ||
Heteroannulation reactions have gained significant importance in organic chemistry. They have been proven to be valuable methods, and vast numbers of heterocyclic molecules have been synthesized. Accordingly, it is not surprising that there are several reports in the literature for the synthesis of heterocyclic compounds using this heteroannulation reaction.5
In the last few decades, much effort has been devoted to developing transition metal catalyzed reactions for the facile construction of the skeleton of heterocycles, in particular Lewis acid catalyzed annulation processes.6 In recent years zinc triflate has been employed as catalyst in a wide range of organic syntheses.7 We have recently reported an efficient general route for the synthesis of RuCl3/SnCl2 mediated pyrrolo[2,3-c]carbazoles in good yield.3d In this context, we wish to continue to develop efficient methods for the synthesis of this class of compounds, especially routes based upon easily prepared starting materials.
Herein, we report a highly efficient method for the regioselective synthesis of pyrrolo[2,3-c]carbazole scaffolds via a zinc triflate promoted heteroannulation reaction (Scheme 1). The reaction is catalyzed by 10 mol% Zn(OTf)2, using which it is possible to couple 3-aminocarbazole with propargyl alcohol in good yield.
![]() | ||
| Scheme 1 Schematic representation of present work. | ||
| Entry | Catalyst | Solvent | Time (h) | Temp. (°C) | Yieldg (%) |
|---|---|---|---|---|---|
| a Unless otherwise indicated, all the reactions were conducted in a RB using 9-ethyl-3-aminocarbazole 1a (1 equiv.), propargyl alcohol 2a (1.5 equiv.) catalyst (10 mol%), and 10 mL solvent. b 5 mol% catalyst used. c Reaction conducted in a pressure tube with 3 mL solvent. d 1.0 equiv. of 2a was used. e 15 mol% catalyst used. f Toluene or dioxane. g Isolated yields. | |||||
| 1b | Zn(OTf)2 | Dioxane | 6 | 110 | 35 |
| 2 | La(OTf)3 | Toluene | 24 | 110 | 25 |
| 3 | In(OTf)3 | Toluene | 8 | 110 | 71 |
| 4 | InCl3 | Toluene | 20 | 110 | 61 |
| 5c | InCl3 | Toluene | 8 | 130 | 30 |
| 6 | La(OTf)3 | Toluene | 8 | 110 | 21 |
| 7c | Zn(OTf)2 | CH3CN | 8 | 100 | 15 |
| 8 | Zn(OTf)2 | CH3CN | 8 | 100 | 62 |
| 9d | Zn(OTf)2 | Toluene | 4 | 110 | 45 |
| 10 | Zn(OTf)2 | Toluene | 4 | 110 | 75 |
| 11e | Zn(OTf)2 | Toluene | 10 | 120 | 75 |
| 12 | Zn(OTf)2 | Toluene | 10 | 70 | 32 |
| 13 | CAN | Toluene | 12 | 110 | 8 |
| 14 | InCl3 | Dioxane | 12 | 110 | 43 |
| 15 | InCl3 | THF | 10 | 80 | — |
| 16 | Cu(OTf)2 | Solventf | 24 | 110 | — |
| 17 | Ag(OTf) | Solventf | 24 | 110 | — |
| 18 | Sc(OTf)3 | Toluene | 10 | 110 | 35 |
| 19 | Zn(OAc)2 | Toluene | 8 | 110 | 12 |
| 20 | ZnCl2 | Toluene | 8 | 110 | 47 |
| 21 | Zn(NO3)2·6H2O | Toluene | 8 | 110 | — |
| 22 | ZnBr2 | Toluene | 8 | 110 | 26 |
| 23 | ZnCO3 | Toluene | 12 | 110 | — |
| 24 | Zn(OTf)2 | THF | 12 | 80 | 47 |
| 25 | La(OTf)3 | DMA | 8 | 120 | — |
| 26 | p-TSA | Toluene | 8 | 110 | 16 |
| 27 | Zn(OTf)2 | DMF | 8 | 110 | — |
| 28 | — | Toluene | 24 | 120 | — |
We first examined the influence of triflates. Different triflate sources were examined, and 10 mol% Zn(OTf)2 showed the highest activity, followed by In(OTf)3 (10 mol%) (Table 1, entries 10 and 3). However, catalysts like La(OTf)3 and Sc(OTf)3 did not facilitate good conversion, and relatively low yields were obtained (Table 1, entries 2, 6 and 18). Catalysts such as Cu(OTf)2 and Ag(OTf) did not produce the above mentioned transformation. When conducted at a moderate temperature of 70 °C with 10 mol% zinc triflate as the catalyst, the reaction proceeded with a lower yield, whereas when it was conducted at higher reaction temperature of 120 °C, the yield did not increase beyond 75% (entries 11–12, Table 1). The screening experiments also showed that increasing the amount of Zn(OTf)2 did not enhance the yield, and even prolonged the reaction time to 10 h. Among the other catalysts, InCl3 promoted the desired annulated product 3a in moderate yield (entry 4).
Of the various zinc salts that were tested in this reaction, zinc triflate gave the best yield when the reaction was conducted in toluene (Table 1, entries 10 and 19–23). A lower yield was obtained when the reaction was carried out with ZnCl2 as the catalyst (Table 1, entry 20). Control experiments showed that omitting the catalyst did not form the product (entry 28). After a comprehensive screening, we found that zinc triflate was superior among all the other catalysts that were examined in this reaction, with a high level of regioselectivity. In(OTf)3 and InCl3 also gave good yields, but zinc triflate gave a somewhat better yield than these catalysts. Moreover, zinc triflate is a commercially cheaper catalyst, and is easier to handle than the other lanthanide triflates and indium catalysts, which require an inert atmosphere for this heteroannulation reaction.
Further inspection of the reaction conditions reveals that the reaction proceeded efficiently in solvents such as CH3CN, THF, and 1,4-dioxane, although they were less efficient compared with toluene. We also checked the effect of the ligands on the reaction yield, and found that they did not play a significant role in this reaction. Various ligands such as dppe, PPh3, dppf, P(OEt)3, and PCy3 were all unimpressive. The use of 1.5 equiv. of 2a rather than 1.0 equiv. improves the yield of the reaction (entry 9, Table 1). The best result was obtained when the reaction was conducted by mixing 1a, 2a and catalyst zinc triflate (10 mol%) successively in toluene, and then refluxing at 110 °C for 4 h to give the desired product 3a in 75% yield (entry 10).
Having identified these optimal conditions, we sought to examine the scope and the generality of the method by applying it to a range of substituted 3-aminocarbazoles and propargyl alcohols, and the results are shown in Table 2. The products 3a–n were generated from 1a–h and 2a–e in moderate to good yields. Notably, regioselectivity was observed in this transformation. All the products displayed spectroscopic data in agreement with the expected pyrrolocarbazoles, and the structures of 3f and 3k were further confirmed by X-ray data.9 From the ORTEP (Fig. 2) we conclude that the methyl group in the product comes from the R6 position of the propargyl alcohol. If R6 = H, the products have a methyl group at the C2 position (which is near to the nitrogen atom), and if R6 = Ph, the products have a benzyl group at the C2 position. The pure products were easily obtained by column chromatography over alumina.
![]() | ||
| Fig. 2 ORTEP of 3f and 3k. | ||
![]() | ||
| Scheme 2 Possible mechanism of the present reaction. | ||
|
|
|||
|---|---|---|---|
| a All the reactions were conducted in a RB using 3-aminocarbazole 1a–n (1 equiv.), propargyl alcohol 2a–e (1.5 equiv.), zinc triflate (10 mol%), and 20 mL of toluene stirred 110 °C. | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
The reaction mechanism (Scheme 2) was proposed on the basis of a literature report.7a The reaction mechanism consists of the following steps: in the first step, hydroamination of the C
C triple bond of the propargyl alcohol takes place. Zinc triflate makes the alkyne carbon electron deficient, thereby facilitating the attack of the nitrogen lone pair on the alkyne carbon, followed by the hydrogen migration which gives rise to the aminoketone structure IA. The migration of the nitrogen lone pair gives rise to structure IIA, and then rearomatization takes place in the carbazole ring, resulting in the structure IIIA. Finally, removal of a water molecule gives the desired product 3a.
:
5 v/v) mixture. The solvent was evaporated to dryness to give the pure product 3a. The same procedure was followed for the preparation of all other products (3b–n).
:
3); Rf = 0.60. 1H NMR (400 MHz, TMS, CDCl3): δ 8.26 (d, 1H, J = 7.6 Hz), 8.02 (s, 1H), 7.49–7.41 (m, 3H), 7.30–7.28 (m, 1H), 7.23–7.21 (m, 1H), 6.80 (s, 1H), 4.44 (q, 2H, J = 7.2 Hz), 2.57 (s, 3H), 1.45 (t, 3H, J = 7.2 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 139.1, 135.1, 135.0, 130.5, 123.7, 123.2, 122.6, 121.3, 118.1, 113.2, 109.1, 108.1, 102.8, 99.2, 37.7, 14.06, 14.01. LC-MS: m/z = 249 (M + H)+, positive mode; Anal. calcd for molecular formula C17H16N2; C, 82.22; H, 6.49; N, 11.28%; found: C, 82.36; H, 6.55; N, 11.15%.
:
3); Rf = 0.52. 1H NMR (400 MHz, TMS, CDCl3): δ 8.23 (d, 1H, J = 7.6 Hz), 8.06 (s, 1H), 7.44–7.41 (m, 3H), 7.28–7.26 (m, 1H), 7.20–7.18 (m, 1H), 6.78 (s, 1H), 3.90 (s, 3H), 2.56 (s, 3H). 13C NMR (100 MHz, TMS, CDCl3): δ 140.1, 136.1, 135.2, 130.5, 123.7, 123.0, 122.4, 121.1, 118.2, 113.0, 109.1, 108.1, 102.7, 99.1, 29.4, 14.0. LC-MS: m/z = 235 (M + H)+, positive mode; Anal. calcd for molecular formula C16H14N2; C, 82.02; H, 6.02; N, 11.96%; found: C, 81.92 H, 6.12; N, 11.78%.
:
3); Rf = 0.62. 1H NMR (400 MHz, TMS, CDCl3): δ 8.23 (d, 1H, J = 7.6 Hz), 8.00 (s, 1H), 7.42–7.36 (m, 3H), 7.24–7.23 (m, 1H), 7.19–7.17 (m, 1H), 6.77(s, 1H), 4.34 (t, 2H, J = 7.2 Hz), 2.52 (s, 3H), 1.87–1.83 (m, 2H), 1.41–1.36 (m, 2H), 0.92 (t, 3H, J = 7.2 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 139.6, 135.5, 135.2, 130.4, 123.7, 123.1, 122.5, 121.2, 118.1, 113.0, 109.0, 108.4, 103.0, 99.1, 43.0, 31.4, 20.6, 14.0, 13.9. LC-MS: m/z = 277 (M + H)+, positive mode; Anal. calcd for molecular formula C19H20N2; C, 82.57; H, 7.29; N, 10.14%; found: C, 82.45; H, 7.23; N, 10.25%.
:
3); Rf = 0.56. 1H NMR (400 MHz, TMS, CDCl3): δ 8.27 (d, 1H, J = 7.6 Hz), 8.05 (s, 1H), 7.39–7.37 (m, 2H), 7.35 (d, 1H, J = 8.4 Hz), 7.27–7.18 (m, 4H), 7.13–7.10 (m, 3H), 6.81 (s, 1H), 5.57 (s, 2H), 2.56 (s, 3H). 13C NMR (100 MHz, TMS, CDCl3): δ 139.9, 137.8, 135.7, 135.4, 130.7, 128.6, 127.2, 126.3, 124.0, 123.3, 122.5, 121.2, 118.6, 113.3, 109.3, 108.6, 103.2, 99.1, 46.7, 14.0. LC-MS: m/z = 311 (M + H)+, positive mode; Anal. calcd for molecular formula C22H18N2; C, 85.13; H, 5.85; N, 9.03%; found: C, 84.91; H, 5.79; N, 9.12%.
:
3); Rf = 0.50. 1H NMR (400 MHz, TMS, CDCl3): δ 8.11 (s, 1H), 8.01 (d, 1H, J = 1.6 Hz), 7.44 (d, 1H, J = 8.4 Hz), 7.31 (d, 1H, J = 2.0 Hz), 7.13 (d, 1H, J = 8.8 Hz), 6.69 (s, 1H), 4.21 (s, 3H), 2.55 (s, 3H). 13C NMR (100 MHz, TMS, CDCl3): δ 137.8, 135.9, 133.8, 130.7, 126.6, 125.0, 123.3, 121.9, 119.2, 115.9, 112.0, 110.7, 102.9, 99.0, 32.2, 14.0. LC-MS: m/z = 301 (M − H)−, 303 (M + 2H)− negative mode; Anal. calcd for molecular formula C16H12N2Cl2; C, 63.38; H, 3.99; N, 9.24%; found: C, 63.45; H, 3.91; N, 9.15%.
:
3); Rf = 0.60. 1H NMR (400 MHz, TMS, CDCl3): δ 8.01 (d, 1H, J = 1.64 Hz), 7.93 (s, 1H), 7.35–7.33 (m, 1H), 7.32 (d, 1H, J = 1.68 Hz), 7.12 (d, 1H, J = 8.8 Hz), 6.65 (s, 1H), 4.72 (q, 2H, J = 6.8 Hz), 2.46 (s, 3H), 1.40 (t, 3H, J = 6.8 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 136.8, 135.9, 133.0, 130.7, 127.0, 125.0, 123.3, 122.0, 119.2, 115.2, 112.3, 110.8, 102.9, 99.0, 39.5, 15.8, 13.9. LC-MS: m/z = 317 (M + H)+, 318 (M + 2H)+ positive mode; Anal. calcd for molecular formula C17H14N2Cl2; C, 64.37; H, 4.45; N, 8.83%; found: C, 64.21; H, 4.51; N, 8.96%.
:
3); Rf = 0.52. 1H NMR (400 MHz, TMS, CDCl3): δ 8.31 (d, 1H, J = 1.6 Hz), 8.08 (s, 1H), 7.49–7.47 (m, 1H), 7.45–7.42 (m, 1H), 7.31–7.29 (m, 1H), 7.18–7.16 (m, 1H), 6.74 (s, 1H), 4.39 (q, 2H, J = 7.2 Hz), 2.56 (s, 3H), 1.41 (t, 3H, J = 7.2 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 137.7, 135.58, 135.52, 130.5, 126.3, 124.9, 123.7, 122.4, 112.3, 110.9, 109.9, 109.5, 102.7, 99.1, 37.9, 13.9. LC-MS: m/z = 325 (M − H)−, 327 (M + 2H)− negative mode; Anal. calcd for molecular formula C17H15N2Br; C, 62.40; H, 4.62; N, 8.56%; found: C, 62.21; H, 4.71; N, 8.45%.
:
3); Rf = 0.76. 1H NMR (400 MHz, TMS, CDCl3): δ 8.26 (s, 1H), 7.85–7.82 (m, 2H), 7.49 (d, 1H, J = 8.0 Hz), 7.44–7.40 (m, 2H), 7.23–7.22 (m, 1H), 4.35 (q, 2H, J = 7.2 Hz), 2.75 (s, 3H), 2.18 (s, 3H), 1.41 (t, 3H, J = 7.2 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 206.3, 169.4, 140.5, 137.6, 128.6, 126.3, 125.0, 123.1, 122.3, 120.8, 119.3, 118.2, 110.6, 109.0, 37.6, 31.8, 24.1, 13.8. LC-MS: m/z = 263 (M + H)+, positive mode; Anal. calcd for molecular formula C18H18N2; C, 82.41; H, 6.92; N, 10.68%; found: C, 82.25; H, 6.98; N, 10.58%.
:
3); Rf = 0.66. 1H NMR (400 MHz, TMS, CDCl3): δ 8.10 (d, 1H, J = 7.6 Hz), 7.95 (s, 1H), 7.68 (s, 1H), 7.38–7.33 (m, 2H), 7.26–7.27 (m, 1H), 7.43–7.16 (m, 6H), 5.55 (s, 2H), 2.42 (s, 3H), 2.25 (s, 3H). 13C NMR (100 MHz, TMS, CDCl3): δ 137.8, 132.5, 131.4, 129.9, 129.2, 128.9, 128.8, 128.6, 127.1, 126.4, 126.3, 124.8, 123.6, 119.5, 118.0, 108.1, 100.4, 95.5, 46.6, 11.9, 8.7. LC-MS: m/z = 325 (M + H)+, positive mode; Anal. calcd for molecular formula C23H20N2; C, 85.15; H, 6.21; N, 8.63%; found: C, 85.02; H, 6.28; N, 8.56%.
:
3); Rf = 0.40. 1H NMR (400 MHz, TMS, CDCl3): δ 9.35 (s, 1H), 8.30 (d, 1H, J = 8.8 Hz), 7.97–7.95 (m, 2H), 7.90–7.88 (m, 1H), 7.58–7.47 (m, 6H), 7.24–7.22 (m, 1H), 4.42 (q, 2H, J = 7.2 Hz), 2.80 (s, 3H), 1.46 (t, 3H, J = 7.2 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 206.4, 165.9, 140.9, 137.4, 134.4, 131.9, 128.8, 127.2, 126.9, 126.3, 126.1, 122.7, 122.1, 120.9, 119.3, 118.7, 111.3, 109.1, 37.7, 31.9, 13.8. LC-MS: m/z =325 (M + H)+, positive mode; Anal. calcd for molecular formula C23H20N2; C, 85.15; H, 6.21; N, 8.63%; found: C, 85.26; H, 6.51; N, 8.81%.
:
3); Rf = 0.66. 1H NMR (400 MHz, TMS, CDCl3): δ 8.24 (d, 1H, J = 7.6 Hz), 7.92 (s, 1H), 7.43–7.42 (m, 2H), 7.35–7.22 (m, 7H), 7.20–7.18 (m, 1H), 6.88 (s, 1H), 4.40 (q, 2H, J = 7.2 Hz), 4.23 (s, 2H), 1.41 (t, 3H, J = 7.2 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 139.1, 138.8, 137.9, 135.0, 130.8, 128.9, 128.7, 126.7, 123.8, 123.2, 122.2, 121.3, 118.2, 113.3, 109.3, 108.2, 103.3, 99.8, 37.7, 34.9, 14.0. LC-MS: m/z = 325 (M + H)+, positive mode; Anal. calcd for molecular formula C23H20N2; C, 85.15; H, 6.21; N, 8.63%; found: C, 85.26; H, 6.15; N, 8.71%.
:
3); Rf = 0.74. 1H NMR (400 MHz, TMS, CDCl3): δ 8.16 (d, 1H, J = 7.6 Hz), 7.87 (s, 1H), 7.37–7.33 (3H, m), 7.27–7.21 (m, 4H), 7.16–7.11 (3H, m), 6.81 (s, 1H), 4.27 (t, 2H, J = 7.2 Hz), 4.17 (s, 2H), 1.78 (pent, 2H, J = 7.2 Hz), 1.34–1.28 (m, 2H), 0.84 (t, 3H, J = 7.2 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 139.6, 138.8, 137.9, 135.5, 130.7, 128.9, 128.7, 128.5, 128.3, 126.7, 123.7, 122.2, 121.2, 118.1, 109.2, 108.4, 103.5, 99.8, 43.0, 35.0, 31.4, 20.5, 13.9. LC-MS: m/z = 353 (M + H)+, positive mode; Anal. calcd for molecular formula C25H24N2; C, 85.19; H, 6.86; N, 7.95%; found: C, 85.21; H, 6.83; N, 7.76%.
:
3); Rf = 0.68. 1H NMR (400 MHz, TMS, CDCl3): δ 8.23 (d, 1H, J = 8.0 Hz), 7.88 (s, 1H), 7.41 (d, 2H, J = 4 Hz), 7.28–7.24 (m, 2H), 7.16–7.09 (m, 5H), 6.84 (s, 1H), 4.36 (q, 2H, J = 7.2 Hz), 4.12 (s, 2H), 2.31 (s, 3H), 1.37 (t, 3H, J = 7.2 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 139.1, 138.3, 136.2, 135.8, 135.0, 130.8, 129.4, 128.8, 123.8, 123.2, 122.3, 121.4, 118.2, 113.3, 109.4, 108.2, 103.2, 99.6, 37.7, 34.5, 21.1, 14.1. LC-MS: m/z = 339 (M + H)+, positive mode; Anal. calcd for molecular formula C24H22N2; C, 85.17; H, 6.55; N, 8.28%; found: C, 85.31; H, 6.45; N, 8.21%.
:
3); Rf = 0.68. 1H NMR (400 MHz, TMS, CDCl3): δ 8.04 (s, 1H), 7.43–7.41 (m, 1H), 7.25–7.23 (m, 1H), 7.06 (s, 1H), 7.03 (d, 1H, J = 7.2 Hz), 6.88–6.86 (m, 1H), 4.68 (q, 2H, J = 7.08 Hz), 3.21 (s, 3H), 2.84 (s, 3H), 2.53 (s, 3H), 1.43 (t, 3H, J = 7.12 Hz). 13C NMR (100 MHz, TMS, CDCl3): δ 138.2, 136.0, 133.5, 131.4, 129.8, 127.5, 123.8, 122.5, 120.4, 117.1, 114.5, 109.4, 103.3, 102.7, 39.4, 24.7, 20.7, 15.6, 13.8. LC-MS: m/z = 277 (M + H)+, positive mode; Anal. calcd for molecular formula C19H20N2; C, 82.57; H, 7.29; N, 10.14%; found: C, 82.68; H, 7.21; N, 10.21%.
Footnote |
| † Electronic supplementary information (ESI) available. CCDC reference numbers 893523–893524. For ESI and crystallographic data in CIF or other electronic format see DOI: 10.1039/c2ra21735j |
| This journal is © The Royal Society of Chemistry 2012 |